Literature DB >> 10651283

A structural model for the rolA protein and its interaction with DNA.

D J Rigden1, M Carneiro.   

Abstract

The study of the plant oncogene rolA has been hampered by a lack of structural information. Here we show that, despite a lack of significant sequence similarity to proteins of known structure, the rolA sequence adopts a known fold; that of the papillomavirus E2 DNA-binding domain. This fold is reliably identified by modern threading programs, which consider predicted secondary structure, but not by others. Although the rolA sequence is only around 16% identical to those of the available template structures, a structural model could be built that performed well against protein structure verification programs. The adopted strategy involved alignment corrections, justified by multiple model building and evaluation, with particular attention paid to the hydrophobic core residues. We find that rolA protein is predicted to resemble the template proteins in two key aspects; existence as a dimer and ability to bind DNA. rolA protein has recently been shown experimentally to possess DNA binding ability. This model predicts Lys 24 and Arg 27 to be involved in sequence-specific interactions and eight other residues to hydrogen-bond phosphate groups of the DNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651283     DOI: 10.1002/(sici)1097-0134(19991201)37:4<697::aid-prot18>3.0.co;2-y

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  2 in total

1.  A cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus is actually a broad specificity phosphatase.

Authors:  D J Rigden; I Bagyan; E Lamani; P Setlow; M J Jedrzejas
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

2.  PrfA protein of Bacillus species: prediction and demonstration of endonuclease activity on DNA.

Authors:  Daniel J Rigden; Peter Setlow; Barbara Setlow; Irina Bagyan; Richard A Stein; Mark J Jedrzejas
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.